Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification

被引:85
作者
Moelans, Cathy B. [1 ]
de Weger, Roel A. [1 ]
van Diest, Paul J. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Pathol, NL-3508 GA Utrecht, Netherlands
关键词
Breast cancer; MLPA; CEP17; Polysomy; HER2; CELL-LINES; TRASTUZUMAB; HER2; GENE; EXPRESSION; DOCETAXEL; PATTERNS; THERAPY; REVEALS; TUMORS;
D O I
10.1007/s10549-009-0539-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Amplification of the HER2 gene, present in 15-30% of breast carcinomas, correlates with poor outcome and is an indication for treatment with trastuzumab. Standard testing methods for HER2 amplification are fluorescence (FISH) or chromogenic in situ hybridization (CISH). In FISH/CISH scoring, correction for chromosome 17 polysomy is believed to be critical for determination of true HER2 amplification as opposed to increased chromosome 17 copy number. The term "polysomy 17" is widely used and defined as a parts per thousand yen3 copies of the chromosome 17 centromere (probe CEP17, D17Z1). Thus, the centromere is assumed to be representative for the entire chromosome. This study aimed to investigate the frequency of polysomy 17 and its association with HER2 amplification in 111 invasive breast cancer patients by CEP17 CISH and by copy number analysis of a set of 17 genes along chromosome 17 using multiplex ligation-dependent probe amplification (MLPA). Chromosome 17 usually showed a complex pattern of gains and losses by MLPA, unrelated to the copy number status of the centromere. Increase in centromere 17 copy number (denoted "polysomy 17"), as assessed by CEP17 CISH, was found in 19% of the patients. Of these patients, 60% also showed amplification of HER2 measured by MLPA. However, none of the 111 patients showed a true polysomy of chromosome 17 by MLPA. Only two patients (1.8%) had a possible gain of 17q. Amplification of 17p was not found in any of the patients, although a possible loss of 17p was found in one patient. In conclusion, this extensive analysis of amplicons along chromosome 17 shows that true polysomy of chromosome 17, either of the whole chromosome or of the short or the long arm, is very rare in invasive breast cancer. Abnormal CEP17 copy numbers may therefore actually stem from high level gains or amplification of CEP17 regardless of copy number gains of the short and long arms of chromosome 17 and, at least in some cases, correction with CEP17 probes may provide misleading HER2 gene status assessment results.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 27 条
[1]   THE PRODUCT OF THE HUMAN C-ERBB-2 GENE - A 185-KILODALTON GLYCOPROTEIN WITH TYROSINE KINASE-ACTIVITY [J].
AKIYAMA, T ;
SUDO, C ;
OGAWARA, H ;
TOYOSHIMA, K ;
YAMAMOTO, T .
SCIENCE, 1986, 232 (4758) :1644-1646
[2]   Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array [J].
Andre, Fabrice ;
Job, Bastien ;
Dessen, Philippe ;
Tordai, Attila ;
Michiels, Stefan ;
Liedtke, Cornelia ;
Richon, Catherine ;
Yan, Kai ;
Wang, Bailang ;
Vassal, Gilles ;
Delaloge, Suzette ;
Hortobagyi, Gabriel N. ;
Symmans, W. Fraser ;
Lazar, Vladimir ;
Pusztai, Lajos .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :441-451
[3]   Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines [J].
Arriola, Edurne ;
Marchio, Caterina ;
Tan, David Sp ;
Drury, Suzanne C. ;
Lambros, Maryou B. ;
Natrajan, Rachael ;
Rodriguez-Pinilla, Socorro Maria ;
Mackay, Alan ;
Tamber, Narinder ;
Fenwick, Kerry ;
Jones, Chris ;
Dowsett, Mitch ;
Ashworth, Alan ;
Reis-Filho, Jorge S. .
LABORATORY INVESTIGATION, 2008, 88 (05) :491-503
[4]  
Bartlett JM, 2009, CANC RES S2, V69, P11
[5]   MLPAnalyzer: Data analysis tool for reliable automated normalization of MLPA fragment data [J].
Coffa, Jordy ;
van de Wiel, Mark A. ;
Diosdado, Begona ;
Carvalho, Beatriz ;
Schouten, Jan ;
Meijer, Gerrit A. .
CELLULAR ONCOLOGY, 2008, 30 (04) :323-335
[6]  
Coon JS, 2002, CLIN CANCER RES, V8, P1061
[7]  
Courjal F, 1997, CANCER RES, V57, P4368
[8]   The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast - A fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study [J].
Downs-Kelly, E ;
Yoder, BJ ;
Stoler, M ;
Tubbs, RR ;
Skacel, M ;
Grogan, T ;
Roche, P ;
Hicks, DG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) :1221-1227
[9]  
Forozan F, 2000, CANCER RES, V60, P4519
[10]   Novel patterns of genome rearrangement and their association with survival in breast cancer [J].
Hicks, James ;
Krasnitz, Alexander ;
Lakshmi, B. ;
Navin, Nicholas E. ;
Riggs, Michael ;
Leibu, Evan ;
Esposito, Diane ;
Alexander, Joan ;
Troge, Jen ;
Grubor, Vladimir ;
Yoon, Seungtai ;
Wigler, Michael ;
Ye, Kenny ;
Borresen-Dale, Anne-Lise ;
Naume, Bjorn ;
Schlicting, Ellen ;
Norton, Larry ;
Hagerstrom, Torsten ;
Skoog, Lambert ;
Auer, Gert ;
Maner, Susanne ;
Lundin, Par ;
Zetterberg, Anders .
GENOME RESEARCH, 2006, 16 (12) :1465-1479